CervoMed Inc. Stock Analysis & AI Score
CervoMed Inc. (CRVO) has an ST Score of 47.0 (C+), driven by its Growth (A) and held back by its Profitability (F). Analysts rate it Buy with a $7.00 price target (+177.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
CervoMed Inc. (CRVO) has an ST Score of 47.0 (C+), driven by its Growth (A) and held back by its Profitability (F). Analysts rate it Buy with a $7.00 price target (+177.8% upside).
- Strongest
- GrowthA
- Weakest
- ProfitabilityF
All factor grades
- GrowthA
- ForecastA
- Financial StrengthA-
- MomentumC-
- ValuationD
- ProfitabilityF
- Piotroski2/9
Contact
CRVO stock: frequently asked questions
What is CRVO's ST Score?
CervoMed Inc. (CRVO) has an ST Score of 47.0 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CRVO a buy, hold, or sell?
Analysts rate CRVO a Buy, with a price target of $7.00 (+177.8% vs the current price). Our ST Score grades it C+ (47.0/100). The ST Score is a data-driven signal, not a recommendation.
What are CRVO's factor grades?
Valuation D, Profitability F, Financial Strength A-, Momentum C-, Growth A, Forecast A.
What is CRVO's valuation grade?
CervoMed Inc. (CRVO) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CRVO's growth grade?
CervoMed Inc. (CRVO) earns a growth grade of A, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CRVO's profitability grade?
CervoMed Inc. (CRVO) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CRVO's financial strength grade?
CervoMed Inc. (CRVO) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CRVO?
The average analyst price target for CervoMed Inc. (CRVO) is $7.00 from 7 analysts, which is +177.8% versus the recent price of $2.52.
What is CRVO's Piotroski score?
CervoMed Inc. (CRVO) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.